Skye Bioscience, Inc. (SKYE)

1.02 +0.04 (+4.02%) USD  |  NASDAQ  |  Jan 22, 11:16
More

Skye Bioscience Current Deferred Revenue (Per Share)

Current Deferred Revenue (Per Share) Chart

View Current Deferred Revenue (Per Share) for SKYE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Per Share) Range, Past 5 Years

View Current Deferred Revenue (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Per Share) Benchmarks

View Current Deferred Revenue (Per Share) Benchmarks
Start Trial
Perspective Therapeutics, Inc. Upgrade
Theravance Biopharma, Inc. --
Viking Therapeutics, Inc. --
Kyntra Bio, Inc. Upgrade
Myomo, Inc. Upgrade